Illumina, Inc. (NASDAQ: ILMN) Q4 2020 earnings call dated Feb. 11, 2021 Corporate Participants: Juliet Cunningham — Vice President, Investor Relations Francis deSouza — President & Chief Executive Officer Sam Samad — Senior Vice President & Chief Financial Officer Analysts: Daniel Brennan — UBS — Analyst Tycho W. Peterson — J.P. Morgan — Analyst Doug Schenkel — Cowen and Company — Analyst Puneet Souda — SVB Leerink Partners —...
Illumina, Inc. (ILMN) Q4 2020 Earnings Call Transcript
Tags: Diagnostics & Research
Related Post
- Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%
Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales…
-
Everything you need to know about Aktis Oncology’s upcoming IPO
IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors,…
-
Pfizer affirms FY25 earnings guidance, provides full-year 2026 outlook
Pfizer Inc. (NYSE: PFE) has reaffirmed its earnings outlook for fiscal 2025 and revised revenue…